Science News
from research organizations

Prescription drug expenses in Canada are a health-care barrier

Date:
September 16, 2013
Source:
Canadian Medical Association Journal
Summary:
High drug expenses in Canada are a substantial barrier for people to access prescription drugs outside of hospital, states an analysis in CMAJ.
Share:
       
FULL STORY

High drug expenses in Canada are a substantial barrier for people to access prescription drugs outside of hospital, states an analysis in CMAJ (Canadian Medical Association Journal).

Canada lacks a national pharmacare program, with drug costs borne by patients and a mix of private and publicly funded drug plans. Most insurance plans require copayments by patients, which can present a barrier to accessing needed drugs. Although provincial governments cover most or all drug costs for seniors and people on social assistance, the "working poor" do not have the same benefits, which can result in high rates of noncompliance and failure of patients to have their prescriptions filled.

"Patient-borne expenses for prescription drugs are an important issue and can have a negative impact on treatment access and outcomes," writes Dr. Braden Manns, University of Calgary, with coauthors. "Without better drug coverage systems, Canadians do not have universal health coverage."

Canada's patchwork system has many players who influence patient-related drug expenses, including federal and provincial-territorial governments, insurers and physicians. Physicians, for example, are often unaware of the difference in costs between two drugs with similar efficacy; they may prescribe a more expensive drug without recognizing the financial burden it may impose on a patient.

The authors recommend several solutions to these barriers including creating a national drug agency, changing the way Canada regulates patented drug prices, differential copayments for medications based on ability to pay or clinical value of a drug, and educating physicians on drug costs.

"A national drug agency would be well positioned to implement a universal drug program, where all Canadians would have access to some type of drug coverage," although the authors acknowledge barriers to a national plan.


Story Source:

The above post is reprinted from materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Karen L. Tang, William A. Ghali, and Braden J. Manns. Addressing cost-related barriers to prescription drug use in Canada. Canadian Medical Association Journal, September 2013 DOI: 10.1503/cmaj.121637

Cite This Page:

Canadian Medical Association Journal. "Prescription drug expenses in Canada are a health-care barrier." ScienceDaily. ScienceDaily, 16 September 2013. <www.sciencedaily.com/releases/2013/09/130916122007.htm>.
Canadian Medical Association Journal. (2013, September 16). Prescription drug expenses in Canada are a health-care barrier. ScienceDaily. Retrieved August 30, 2015 from www.sciencedaily.com/releases/2013/09/130916122007.htm
Canadian Medical Association Journal. "Prescription drug expenses in Canada are a health-care barrier." ScienceDaily. www.sciencedaily.com/releases/2013/09/130916122007.htm (accessed August 30, 2015).

Share This Page: